Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Vericel (VCEL) Return on Sales (2016 - 2025)

Historic Return on Sales for Vericel (VCEL) over the last 16 years, with Q3 2025 value amounting to 0.08%.

  • Vericel's Return on Sales rose 900.0% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.04% for FY2024, which is 600.0% up from last year.
  • According to the latest figures from Q3 2025, Vericel's Return on Sales is 0.08%, which was up 900.0% from 0.01% recorded in Q2 2025.
  • In the past 5 years, Vericel's Return on Sales registered a high of 0.26% during Q4 2024, and its lowest value of 0.24% during Q2 2022.
  • For the 5-year period, Vericel's Return on Sales averaged around 0.05%, with its median value being 0.09% (2024).
  • Data for Vericel's Return on Sales shows a peak YoY increase of 3200bps (in 2021) and a maximum YoY decrease of -2600bps (in 2021) over the last 5 years.
  • Vericel's Return on Sales (Quarter) stood at 0.1% in 2021, then grew by 18bps to 0.11% in 2022, then soared by 78bps to 0.2% in 2023, then skyrocketed by 31bps to 0.26% in 2024, then plummeted by -71bps to 0.08% in 2025.
  • Its Return on Sales stands at 0.08% for Q3 2025, versus 0.01% for Q2 2025 and 0.21% for Q1 2025.